cell, where they acted independently. Determinants active in bacteriocin production were also constructed by crosses involving two nonproducing parents. Resistance to pneumocin B4 was a property of cells of the P4 type which produced it. On selection of pneumocin-resistant cells resulting from mutation or transformation in strain R6, resistant cells, all of which were pneumocin producers, were obtained. The genetic determinants of B4 production and resistance were transferred together in transformation. A gene for high level B4 resistance was found in strain P7S. This gene was not associated with B4 production and did not induce production when introduced into R6, although it did increase resistance to B4. Pneumocin B4 was bactericidal and caused a rapid cessation of growth. Its action was inhibited by pronase, trypsin, chymotrypsin, and phospholipids.
Bacteriocins are substances of a protein nature, inhibitory or lethal to strains of bacteria closely related to the producers (15) . They appear to be of ubiquitous occurrence, having been found in a host of bacterial genera (8) . Although some of the general characteristics of these systems have been known for many years, there does not exist at the present time a satisfactory explanation for the mechanism of either their production or the specificity of their action. In this report a system of bacteriocins elaborated by strains of Diplococcus pneumoniae are described. Some of the characteristics of the system have been elucidated through the use of genetic operations such as mutation and transformation with derivatives of the widely employed strain R36A (2) .
MATERIALS AND METHODS
Bacterial strains. The strains of D. pneuimonziae employed most extensively in this study are listed in Table 1 . In addition, 18 strains of the same species, including long-established as well as freshly isolated cultures of capsule types I through VIII, were used but were found neither to produce nor to exhibit sensitivity to pneumococcal bacteriocins. Streptomycin-resistant derivatives of some strains were isolated by means of a single exposure to 150 ,ug/ml of dihydrostreptomycin sulfate (Calbiochem); these mutants are designated P2S, P4S, P5S, P7S, and P12S.
Culture media. Cultures were usually grown and stored frozen in Neopeptone (Difco)-meat infusionyeast extract broth (13) , designated as BIB. BIA was similar to this broth but contained 0.6 or 1.5% agar. M3 contained (per liter) Vitamin Free Casamino Acids (Difco), 10 g; Neopeptone (Difco), 10 g; sodium chloride, 8.5 g; sodium maleate (pH 7.5, 1 M), 20 ml; fresh yeast extract (13), 10 ml; glucose, I g; agar, 6 or 15 g. SNPCH is essentially the CH CFU of the strain to be studied. After 18 hr of incubation, the plates were overlaid with 4 ml of the same medium containing 107 CFU of the same or another strain. Zones of inhibition were examined after 6 and 20 hr. Figure 1 illustrates the appearance of inhibition zones obtained by methods A and B.
Determination of resistance to pneumocin B4. Resistance to pneumocin B4 was determined by plating approximately 105 CFU of the test culture in 1.5 ml of M3 (0.6% agar) with DRB and 0.5 or 1 unit of B4 (per milliliter), over 10 ml of M3 (1.5% agar). Under these conditions, at 0.5 units of B4, I observed a confluent growth layer with R6-26 (a derivative of R6 that produces B4; Table 3 ), approximately five colonies with R6, and no colonies with P2 or P7.
Genetic tranisformation. Deoxyribonucleic acid (DNA) was isolated from sodium lauryl sulfate lysates by phenol deproteinization, ribonuclease treatment, and several alcohol precipitations (17) , and transformation procedure differed here only in that cells were plated in BIA or M3 90 min after termination of exposure to DNA. For assay of bacteriocin transformation, plates were incubated for 18 hr and then overlayered with the same agar containing 107 CFU of a given sensitive strain. Figure IC illustrates the appearance of a plate after transformation. Strains used for DNA preparation were resistant to streptomycin.
Since the determinant for this marker is transformed at high frequency in all of our strains, one can eliminate the effects of variables such as relative competence of recipient strains by relating transformation frequencies of bacteriocin determinants to that of streptomycin resistance.
Mutagenesis. Strain R6 was grown to 108 CFU per ml, and 1 ml was added to 9 ml of 0.10 M sodium acetate (pH 6.0), 0.04% bovine serum albumin (Armour, fraction V), and 300 ,ug of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG; Aldrich Chemical Co., Inc., Milwaukee, Wis.). After 30 min of incubation at 37 C, the suspension was centrifuged, suspended in BIB, and incubated overnight. This culture was plated out and overplated as for the demonstration of bacteriocin production or resistance, and pneumocin-producing or -resistant colonies were picked and purified.
Isolation of bacteriocin B4. Five liters of SNPCH containing about 0.25 g/liter of tryptic digest of casein and 0.014 M DMAE (Eastman Organic Chemicals) were inoculated with 1010 CFU of P4 or R6-26 in 100 ml of the same medium and incubated at 37 C until 1 hr after the optical density at 550 m, ceased to increase. The culture was centrifuged at 12,000 X g. and ammonium sulfate was added to the supernatant fluid to obtain 75% saturation. The precipitate was allowed to stand overnight, and was then collected by centrifugation and dissolved in water; finally, the material precipitable from 30 to 55% saturation was collected and dissolved in about 30 ml of water. This was the B4 concentrate. It was stable for at least 4 months at -20 C.
Another method of preparation was to add 100 mg of bentonite (5) to the supernatant liquid of the above culture, isolate the bentonite by centrifugation, wash once with 12 ml of water, and extract twice with 8 ml of 10% pyridine (pH 5.5). This second method yielded a larger amount of a purer product. Activity was assayed by placing droplets of diluted solutions on the surface of plates recently overlayered with approximately 108 CFU of sensitive bacteria. The unit of pneumocin activity is that concentration which produces a zone of inhibition exactly equal in area to that caused by a droplet of 0.02 cc placed on the surface of a plate containing the sensitive organisms, usually P7S.
RESULTS
Antagonistic relationships. Of 30 strains tested against each other by layering confluent growth layers over stabs in BIA (method A), 14 were sensitive to the products of others, and 10 were found to inhibit the growth of at least one other strain. The degree of inhibition varied from barely discernible to zones of 6-mm radius. Most strains that produced inhibitor were sensitive to at least one other producer. Examples of the activity spectra of several strains are illustrated in Table 2 . The various strains did not inhibit the growth of their own streptomycin-resistant derivatives. They did not usually inhibit themselves either. It is also clear that capsule production did not necessarily play a role in the antagonistic relationships; e.g., P2 is the unencapsulated derivative of P1 (Table  1) , and both had essentially the same pattern of production. The patterns of sensitivity were also similar to P1 and P2.
This report deals primarily with the differences manifest between P2 and P4. They are considered prototypes for the production of two different pneumocins, B2 and B4. Cells having a production and sensitivity pattern similar to P4 are designated "P4 type"; those similar to P2 are designated "P2 type." Thus, P1 is of the P2 type. The two types differed in that each was immune to its own products, while inhibiting strains of the other as well as P7S (Table 2 ). It has not been established whether these inhibitory products are complex mixtures or are pure. If B4 denotes several substances, then one can say on the basis of mutation and transformation data that its elaboration is controlled by a set of closely linked and interdependent genes, since the various inhibitory activities always appear together. The environmental requirements for pneumocin production and action have been studied extensively and were found to be quite complex; parameters of importance were ionic strength, pH, temperature, and presence of particular peptides and miscellaneous substances such as formate, carbonate, and tertiary and quaternary amines (unpublished data).
Mutation P4 has been found to produce pneumocin in broth cultures and on agar plates containing blood or DMAE. P4 was also fairly resistant to B4, the bacteriocin it produces; R6 was sensitive to B4. A simple means of differentiating P4 and R6 is to study pneumocin production on plates containing DRB or DMAE; under these conditions, R6 produced very slight inhibition of P7 or P7S, whereas P4 was very inhibitory, causing zones of inhibition of 2 to 3 mm (radius) around isolated colonies. Mutants inhibiting P7 on blood plates were isolated with a frequency of 4 X 10-5 per CFU from cultures of R6. These spontaneous mutants showed a pattern of antagonism quite similar to that of P4; they were also resistant to B4. Mutants were isolated at higher frequencies (4 X 10-4) after treatment with MNNG, with R6-17 being an example. This strain also showed a pattern similar to P4 (Table 3) .
Spontaneous mutants of R6 were also obtained by selecting for cells resistant to B4. All of 16 clones isolated were found to be producers of bacteriocin on blood plates. The pattern of production for these mutants (12) or to the frequency of streptomycin resistance transformation (Fig. 2) Strain R6 can also be transformed to pneumocin production or resistance with DNA from strains of other than P4 specificity. In the experiment shown in Table 4 , R6 was exposed to DNA of strains P2S, P4S, P5S, P7S, P12S, and a streptomycin-resistant R6. The cultures were then tested for transformation to streptomycin resistance and B4 resistance. DNA from R6, as expected, did not mediate B4 resistance transformation, and DNA of P4S did; however, at very low frequencies, P2S, P5S, P7S, and P12S DNA samples mediated transformation to B4 resistance. The last four strains were all sensitive to B4; nevertheless, their DNA apparently contained part of the P4 genetic material. All of the B4-resistant transformants were found to be pneumocin producers of the P4 type. The frequency of transformation of streptomycin resistance was very similar with all preparations except P12S DNA. The similarity in streptomycin resistance transformation frequencies implies that the DNA was intact to the same degree in all the preparations and that the efficiency of transformation was not greatly affected by a possible lack of homology between the DNA of the various strains and that of R6.
The low frequency of transformation to B4 resistance is best explained by assuming that R6, on one hand, and strains P2, P5, P7, and P12, on the other, have complementary deficiencies in the B4 genetic determinant. If this is so, then the construction of an active B4 determinant would involve an intragenic recombination. The frequency of this recombination should be much lower than that necessary to introduce an entire gene, such as that for streptomycin resistance or (see below) B2 production. The reciprocal cross between R6 DNA and strains P2, P5, or P7 could not be performed satisfactorily owing to the relative incompetence of these cultures in transformation.
When, instead of selecting for B4-resistant transformants, pneumocin production directed against P7 or P4 was selected for, the following was apparent. DNA from P2S transformed R6 so that it produced a bacteriocin of the P2 type (Table 3 ). These cells were still sensitive to B4. This transformation occurred at a much higher frequency than the transformation to B4 resistance, as illustrated in an experiment in which Table 3 ).
R6-26 (a strain of R6 transformed to B4 production by DNA of P4S) was further transformed with P2S DNA. This yielded clones which killed both P2-and P4-type cells but which were immune to both types of pneumocin (Tables  3 and 5 ). The cells containing both B2 and B4 determinants were immune to their own products as well as to the products of strains P2 and P4 (see strain R6-26T2 in Table 5 ). This finding suggested that the determinants for pneumocins B2 and B4 are independent in the cell. This possibility was tested in a back-cross of a di-pneumocinogenic strain to R6. DNA from a strain of R6 sequentially transformed to B4 production, B2 production, and streptomycin resistance was added to a culture of R6. Transformants were scored for production of inhibitors of P4S and P7S and for resistance to streptomycin and pneumocin B4 (0.5 unit/ml). The P7S. Reconstruction experiments showed that expression of pneumocin production was not always complete on plates crowded with nonproducing colonies. All 69 B4-resistant isolates tested for inhibition of P2S, P4S, and P7S inhibited P2S and P7S; none inhibited P4S (P4 type). Of 78 P7S inhibitors, 34 were B4-resistant, inhibited P2S and P7S but not P4S (P4 type); the remaining 44 were B4-sensitive, inhibited P4S and P7S, but did not inhibit P2S (P2 type). [P2S was, in fact, inhibited to a very slight degree by the R6 transformed to P2 type (of R6T2 in Table 3 ).] Of 19 P4S inhibitors, 18 inhibited growth of P4S and P7S and were sensitive to B4 (P2 type); the remaining one inhibited P2S, P4S, and P7S and was B4-resistant. This may have been a double transformant. It should be recalled that P7 was inhibited by B4 and B2, whereas P4 was inhibited only by B2.
It is seen that all B4-resistant cells were of the P4 type when tested against P2, P4, and P7; all but one of the clones that were found to inhibit P4 were of the P2 type and were sensitive to B4. The exception was probably a double transformant to B4 and B2 activity. Of the clones that were picked because of inhibition of P7, about half (55%) were of the P2 type on the basis of production and B4 sensitivity, and half were of the P4 type. These results demonstrate that the two determinants do reside and act independently in the pneumococcal genome. High level B4 resistance. A mutant of P7S was found that had the property of relatively high B4 resistance. It was only as resistant as R6, but, since this marked a great increase in resistance over the parental level, the property was studied further. Strain R6 was transformed with DNA from the resistant mutant. The transformants, which were as frequent as streptomycin-resistant transformants, were more resistant to B4 than was R6-26 or P4. However, they did not produce B4. Associated with this high-level resistance in R6 transformants was incompetence in genetic transformation. All R6 transformants to high-level resistance lost their ability to transform to streptomycin resistance. This new resistance determinant was not found to be genetically linked to the B4 region. Strain R6-26 was transformed simultaneously to streptomycin resistance and high-level B4 resistance. DNA from this strain (P91) was used to transform R6. Cells were scored for streptomycin resistance and for B4 resistance at 1 and 0.5 unit/ml (Table 6) . Cells of high resistance survived 1 unit of B4 per ml; normal P4-type cells survived 0.5 unit of B4 per ml. There were almost twice as many resistant cells at 0.5 unit/ml as at 1 unit/ml. All VOL. 92, 1966 of 10 colonies tested from the high-level screening were highly resistant upon further testing. None of these produced B4. Of 25 picked from the 0.5 unit/ml screening, 11 were producers, and none of these was more resistant than R6-26. The remaining 14 were highly resistant but not producers. I conclude from this experiment that the two determinants are independent genetically and functionally.
Transformation to capsule production. The various pneumocins were produced in and acted on both encapsulated and nonencapsulated cells ( Tables 1 and 2 sulfate at pH6. The inhibitory activity is destroyed by trypsin (Worthington, twice crystallized) and chymotrypsin (Worthington, three times crystallized), pronase (Calbiochem), and natural phospholipids; it is not associated with the pneumococcal hemolysin. The activity is not affected by ribonuclease, deoxyribonuclease, phospholipase C or D, or lysozyme. The effect of B4 on the turbidity of a growing culture of P7 is shown in Fig. 3 , as is the effect of trypsin on this inhibition. The bacteriocin stops growth quickly, and lysis occurs after 30 to 60 min. The action of the bacteriocin on the susceptible cell is similar to that of other bacteriocins of gram-positive organisms and will be described more fully in another publication.
DiSCUSSION
The substances called bacteriocins do not constitute a homogeneous class. Many of them have unique properties or are found in unique structures. Megacin A (a product of B. megaterium) is an extremely acidic protein (10) that appears to destroy permeability functions in sensitive cells (14) , whereas megacin C appears to cause the aerobic destruction of cellular DNA (11) . A bacteriocin of S. zymogenes (3) having a range of action extending to other genera has been identified with a hemolysin; colicin K has been identified as a component of the mucolipoprotein somatic antigen of Escherichia coli. Some bacteriocins have a limited range of action, others extended. The production of some is induced by ultraviolet light, but not that of others (8) . The bacteriocins share, with a few exceptions, the property of inhibiting primarily organisms closely related to the producers.
The pneumocins, as we shall call the pneumococcal bacteriocins, are similar to most other bacteriocins in that-they exhibit a limited range of action with respect to sensitive strains. They are clearly proteinaceous, as attested to by their sensitivity to proteolytic enzymes. They are similar to many other bacteriocins of grampositive bacteria, in that they act quickly and irreversibly. Ability to produce a pneumocin and resistance to it appear to be controlled by the same genetic locus, but another gene was shown to exist that by itself can confer high resistance. This difference in relative resistance has been observed before in the colicins (7). In the enteric bacteria, it was found that resistance to a given colicin is stronger in the resistant mutants than in the case of production immunity. In pneumococcus, a mutation to simple resistance confers a higher level of B4 tolerance than does production immunity. It seems likely that the cause, or even site, of resistance may differ considerably in the two cases, since resistance due to production immunity does not lead to a loss of competence of genetic transformation, whereas simple resistance does.
The different pneumocins are clearly independent of each other. As with the Enterobacteriaceae studied by Fred6ricq (6), more than one bacteriocin can be transferred to the same culture. These pneumocins, like the colicins, are not closely linked genetically and may be transferred independently. Resistance to one pneumocin can vary independently of other resistances. The determination of whether the genetic determinants for pneumocin structure are genetically integrated with the other pneumococcal genes in a larger chromosome awaits the development of a large-scale mapping procedure for pneumococcus.
In the light of indications that some bacteriocins (8) and, in particular, pneumocins (unpublished data) act on cell membranes, it may be that this structure is the site of normal function in producing cells and lethal action in sensitive ones. Perhaps the pneumocins are variants of normal membrane proteins; however, it is not yet clear whether pneumocin production involves mutation in a structural gene to form a potentially lethal protein or in a control gene to determine whether a particular protein is produced or perhaps overproduced. The pneumocins could be normal proteins produced in excess by so-called producing strains.
The observation that R6 produces under some conditions what seems to be a bacteriocin similar to B4 supports the contention that it has the complete structural gene for B4 but is "switched off' in a controlling gene. The transformation of R6 into a B4 producer by means of exposure to DNA from other strains is consistent with this view; the control gene could be common to donors of the non-P4 type. However, if there are pneumocin control genes, there must be distinct ones for the different pneumocins, since R6 can be transformed to P2 type without producing B4.
It is also possible that R6 produces a pneumocin similar to but not as lethal as B4. Transformation or mutation might involve a change in the structural gene. This seems to be the case with colicin K in E. coli and Shigella sonnei, in which the somatic antigen is elaborated to the same extent by colicinogenic and nonproducing cultures alike (9) . It seems that this question must remain open until methods are developed to increase the yield of pneumocin to a level where chemical analysis of these substances is possible.
